RDY241115P85000
- 6.33
- 0.000.00%
Dr. Reddy's Laboratories Newsroom
Trump Sees Harris's Fox Interview as 'Tough but Very Fair'
Trump, big comeback! Is the 'Trump trade' making a comeback?
"Trump trade" is gaining momentum. The long-dormant "Trump trade" seems to be making a comeback. Among them, the stock price of the Trump Media and Technology Group has been soaring, with the stock price skyrocketing over 15.5% on October 16th Eastern Time, a cumulative increase of over 166% compared to the September low. At the same time, the "Trump trade" is boosting the prices of bitcoin and the US dollar. On the news front, there has been a major turnaround in Trump's election prospects. As of October 16th local time, a latest nationwide poll released by Fox News shows Trump leading Harris by 50% to 48%, which is different from September.
No matter who takes over the White House, financial trading activities will pick up.
Whether it's Donald Trump or Kamala Harris taking office in the White House, the market generally expects financial trading activities to heat up, bringing good news to Citigroup, Goldman Sachs, JPMorgan, and other major banks.
Express News | According to the average of the betting market provided by the website RealClearPolitics that summarizes gambling odds, as of the evening of October 16th local time, Trump's chances of winning have reached 57.7%, the highest level since July 22, far ahead
The significant risks in November are undergoing crucial changes.
Less than a month away from the usa presidential election day on November 5th, the market is starting to price in the risks of the election results. Currently, Trump has regained a leading advantage, adding variables to the election. CICC believes that for subsequent assets, the overall bullishness of the election is favorable for US stocks but tariffs are unfavorable for chinese assets; the US dollar is relatively strong, gold is neutral, interest rates are rising; bulk commodities may benefit from expectations of Trump's stimulus.
Dr. Reddy's Launches Comprehensive Menopause Support Program And Training For Employees During Menopause Awareness Month
Harris, Trump Tied in Battle for Swing States, WSJ Poll Shows -- WSJ
Alvotech Application for Prolia/Xgeva Biosimilar Accepted by EMA
Asian Equities Traded in the US as American Depositary Receipts Decline in Thursday Trading
Wall Street is "waiting quietly" for the usa election, how will the election trade seize the opportunity?
The USA election is approaching, but Wall Street is surprisingly quiet.
The significant cooling of inflation in the usa, what does it mean for the presidential election?
The retreat of inflation does not mean a decrease in prices. With less than a month left until the usa election, price issues continue to worry voters and become a focal point in the campaign.
usa's 'most controversial' election is approaching, investors are starting to prepare for political risks.
①Investors expect the voting results to be questioned in various ways, potentially the most controversial election in US history; ②UBS Group analyst Kurt Reiman suggested that investors should consider popular safe-haven assets such as utility stocks and gold to hedge against potential political risks.
Who will win, Trump or Harris? The Dow predicts a 92% chance of winning the election.
The performance of the Dow before the election day 11 weeks, is related to whether the ruling party candidate has won the presidential election since 1968.
U.S. Government to Release Preliminary List for Pilot Medicare Program Offering Generics Under $2 - Report
Dr. Reddy's Laboratories To Carry Out 5-for-1 Stock Split On November 5th, 2024
October 8th (Eastern Time) - $Dr. Reddy's Laboratories(RDY.US)$ is about to implement a 5-for-1 stock split of shares. The shares will begin trading on a split-adjusted basis from November 5th, 2024.
Aurigene Oncology Limited Announces Promising Results of Phase 1 Study for India's First Trial for Novel Autologous CAR-T Cell Therapy for Multiple Myeloma
Dr. Reddy's Subsidiary Aurigene Oncology, Announced Phase 1 Results For Ribrecabtagene Autoleucel From SWASTH Study; All 8 Patients Achieved Clinical Response
Dr. Reddy's Signs Voluntary Licensing Agreement With Gilead Sciences To Manufacture And Commercialise Lenacapavir In India And Other Countries
Gilead Sciences Signs Licensing Deals With 6 Drugmakers to Manufacture HIV Prevention Drug Lenacapavir
100 billion US dollars in tax credits! Harris wants to "revitalize American manufacturing"
Harris stated that she will provide funding for the future 100 billion US dollar tax relief over the next ten years by increasing taxes on American companies' overseas income, including biotechnology, aviation, ai, quantum computing and other cutting-edge industries, as well as traditional industries such as iron and steel.